Literature DB >> 11593953

Interpretation of congruent and incongruent affective communications in paranoid schizophrenia.

P J Davis1, K D Stewart.   

Abstract

OBJECTIVES: It was hypothesized that people with paranoid schizophrenia would differ from depressed and normal participants in their interpretation of complex communications in which the affect conveyed verbally was either congruent or incongruent with the affect conveyed non-verbally.
DESIGN: A 3 (group) x 3 (positive, negative, neutral facial expression) x 3 (positive, negative, neutral verbal content) experimental design was used. There were eight participants per group, and the paranoid and depressed groups comprised inpatients in an acute psychiatric facility for either their first or second psychiatric episode.
METHODS: Participants, tested individually, were asked to interpret the affect conveyed by the various communications presented.
RESULTS: All participants interpreted most of the communications in a similar way. Paranoid schizophrenia patients, however, differed in their interpretation of communications in which negative feelings were expressed verbally. In contrast to both the normal and depressed groups, the paranoid schizophrenia group interpreted these communications as virtually devoid of any affect whatsoever.
CONCLUSIONS: Paranoid schizophrenia patients show an information-processing bias in response to communications involving both congruent and incongruent negative verbal content. It is not obvious why the bias observed would be specific to negative verbal messages and not extend to negative non-verbal messages. Replication and further study are required.

Entities:  

Mesh:

Year:  2001        PMID: 11593953     DOI: 10.1348/014466501163661

Source DB:  PubMed          Journal:  Br J Clin Psychol        ISSN: 0144-6657


  1 in total

1.  A study of theory of mind in paranoid schizophrenia: a theory or many theories?

Authors:  Peter Scherzer; Edith Leveillé; André Achim; Emilie Boisseau; Emmanuel Stip
Journal:  Front Psychol       Date:  2012-11-14
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.